JOHNSON & JOHNSON is 298.5x more valuable than Bausch Health Companies Inc. by market capitalization ($574.10 B vs $1.92 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BHC | JNJ |
|---|---|---|
| Market cap | $1.92 B | $574.10 B |
| US-listed rank | #2124 | #20 |
| Revenue (latest FY) | $10.27B | $94.19B |
| Net income (latest FY) | $157.00M | $26.80B |
| Net margin | 1.5% | 28.5% |
| P/E (trailing FY) | 12.3 | 21.4 |
| SEC filings | 2,398 | 984 |
JOHNSON & JOHNSON is 298.5x more valuable than Bausch Health Companies Inc. by market capitalization ($574.10 B vs $1.92 B).
In their latest fiscal years, Bausch Health Companies Inc. reported $10.27B in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: Bausch Health Companies Inc. and JOHNSON & JOHNSON, or browse the full rankings.